使用 CRISPR 揭示癌症依赖性和治疗反应的决定因素

alt text
演讲者
Luke Gilbert
Luke Gilbert
加州大学旧金山分校副教授

本次网络研讨会中涵盖的内容
如何使用 CRISPR 进行功能基因组筛选,以确定治疗癌症的新策略
雄激素受体驱动型前列腺癌所需基因的鉴定
新药和联合治疗反应的决定因素
靶向功能丧失驱动突变(如 TP53 突变型急性髓性白血病)的策略

Genomics and functional genomic approaches are needed to identify new strategies for the treatment of aggressive cancers. We use synthetic biology to build new innovative tools for editing the epigenome and driving innovation in functional genomics. Our efforts are focused on utilizing our CRISPR expertise to tackle big problems such as drug resistance in prostate cancer, leukemia, and lung cancer. We use genome-scale screens and genetic interaction mapping to identify the genetic and epigenetic causes underlying why some patients are cured and others are not by cancer therapy.
 

填写您的详细信息,观看网络研讨会

 

 

Powered by Translations.com GlobalLink Web Software